Governing the AI–biotech convergence
Benjamin D. Trump, Christopher L. Cummings, Beth Ellinport, Stephanie Galaitsi, Thomas Janisko, Elizaveta Pinigina, Hannah Herzig, Cindy Groff-Vindman, Markus Schmidt, Gerald L. Epstein, Ruth Mampuys, Christian Haggenmiller, Tatyana Novossiolova, Travis B. Tubbs, James H. Lambert, Alexander Titus, Igor Linkov · EMBO Reports · 2026
The convergence of artificial intelligence with biotechnology accelerates innovation but also introduces significant ethical and security risks. These require adaptive, flexible governance strategies that ensure that breakthroughs can be managed responsibly while mitigating potential risks.